We also saw strong growth in SANTYL late in the quarter, where as we've said before we see volatile stocking patterns. With all of that in mind, we expect bioactives to return to low-single digit ...

Santyl.” Alongside the VALUE study, MediWound is preparing to commence a head-to-head Phase II trial this year to compare the therapy against collagenase in VLU subjects, supporting the US ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...